Original Research
Published on 31 Oct 2025
Net health benefit of mavacamten for the treatment of Chinese patients with obstructive hypertrophic cardiomyopathy: a model-based economic evaluation
in Translational Pharmacology
- 251 views
Original Research
Published on 31 Oct 2025
in Translational Pharmacology
Original Research
Accepted on 30 Oct 2025
in Translational Pharmacology
Original Research
Accepted on 30 Oct 2025
in Translational Pharmacology
Original Research
Accepted on 30 Oct 2025
in Translational Pharmacology
Original Research
Accepted on 29 Oct 2025
in Translational Pharmacology
Original Research
Accepted on 24 Oct 2025
in Translational Pharmacology
Review
Accepted on 24 Oct 2025
in Translational Pharmacology
Original Research
Accepted on 24 Oct 2025
in Translational Pharmacology
Review
Accepted on 24 Oct 2025
in Translational Pharmacology
Original Research
Published on 24 Oct 2025
in Translational Pharmacology
Original Research
Published on 23 Oct 2025
in Translational Pharmacology
Opinion
Accepted on 22 Oct 2025
in Translational Pharmacology
Original Research
Published on 21 Oct 2025
in Translational Pharmacology
Review
Accepted on 20 Oct 2025
in Translational Pharmacology
Original Research
Accepted on 20 Oct 2025
in Translational Pharmacology
Correction
Published on 20 Oct 2025
in Translational Pharmacology